Holen Sie sich die Stockscreener-App
54.54
0.37%
0.20
Schlusskurs vom Vortag:
$54.34
Offen:
$54.29
24-Stunden-Volumen:
826.35K
Relative Volume:
1.09
Marktkapitalisierung:
$2.63B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$123.81M
KGV:
22.63
EPS:
2.41
Netto-Cashflow:
$20.35M
1W Leistung:
-3.25%
1M Leistung:
-27.80%
6M Leistung:
-15.53%
1J Leistung:
-27.65%
1-Tages-Spanne:
$54.02
$55.12
1-Wochen-Bereich:
$53.90
$56.27
52-Wochen-Spanne:
$50.68
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Branche
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
54.54 | 2.62B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
132.66 | 228.64B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.50 | 156.70B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
391.41 | 148.97B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.81 | 117.96B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.34 | 47.69B | 5.69B | 1.41B | 577.90M | 6.95 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Bestätigt | Barrington Research | Outperform |
| 2025-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-06-26 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-02-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Eingeleitet | CL King | Buy |
| 2024-09-11 | Eingeleitet | BofA Securities | Neutral |
| 2024-09-10 | Eingeleitet | BTIG Research | Buy |
| 2024-06-12 | Hochstufung | Needham | Hold → Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Is Haemonetics Corporation a candidate for recovery play2025 Market Outlook & AI Driven Stock Movement Reports - Newser
Volatility clustering patterns for Haemonetics Corporation2025 Price Action Summary & Detailed Earnings Play Alerts - Newser
Using Python tools to backtest Haemonetics Corporation strategiesJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - Newser
Is this a good reentry point in Haemonetics CorporationMarket Weekly Review & Weekly Top Stock Performers List - Newser
Published on: 2025-08-30 21:51:39 - Newser
Can Haemonetics Corporation hit a new high this monthMarket Volume Summary & Fast Moving Trade Plans - Newser
Analyzing Haemonetics Corporation with multi timeframe chartsJuly 2025 Pullbacks & Growth Focused Stock Reports - Newser
Analyzing net buyer seller activity in Haemonetics CorporationJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Why Haemonetics Corporation stock attracts strong analyst attentionMarket Performance Report & Advanced Technical Signal Analysis - Newser
What moving averages say about Haemonetics CorporationQuarterly Portfolio Review & Precise Trade Entry Recommendations - Newser
Building trade automation scripts for Haemonetics Corporation2025 Big Picture & Real-Time Price Movement Reports - Newser
Is Haemonetics Corporation stock ready for a breakoutWeekly Market Report & Free High Return Stock Watch Alerts - Newser
Is Haemonetics Corporation stock entering bullish territory2025 Sector Review & Technical Confirmation Trade Alerts - Newser
Can machine learning forecast Haemonetics Corporation recoveryWeekly Stock Recap & Real-Time Market Sentiment Alerts - Newser
Haemonetics Corporation $HAE Shares Sold by Northern Trust Corp - Defense World
Zacks Research Lowers Earnings Estimates for Haemonetics - Defense World
Evaluating Haemonetics Corporation with trendline analysisJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser
Haemonetics Corporation Approaches Support With Recovery in SightOil Prices & High Accuracy Swing Entry Alerts - beatles.ru
What candlestick patterns are forming on Haemonetics CorporationMarket Trend Report & Weekly Top Stock Performers List - Newser
Haemonetics Corporation (NYSE:HAE) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Advanced analytics toolkit walkthrough for Haemonetics CorporationTrade Ideas & Daily Stock Momentum Reports - Newser
Quantitative breakdown of Haemonetics Corporation recent moveDividend Hike & Growth Oriented Trading Recommendations - Newser
Haemonetics Corporation $HAE Position Lifted by Invesco Ltd. - Defense World
Can a trend reversal in Haemonetics Corporation lead to recoveryCEO Change & Verified Technical Signals - Newser
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):